Doyle Thomas James
CIK 0001910331
SVP, Finance & Accounting
Filings
11
Latest Jan 27, 2026
Issuers covered
1
Showing
11 of 11
Page 1
Track record
16 of 16 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 16 | 44% | -2.0% | -2.1% | +13.0% | -14.9% |
| 90 days | 16 | 44% | +4.8% | -7.1% | +29.5% | -16.5% |
| 180 days | 11 | 73% | +11.7% | +20.3% | +27.3% | -12.2% |
| 365 days | 9 | 33% | +9.8% | -3.5% | +58.2% | -36.4% |
Issuers
Companies where Doyle Thomas James has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KURA | Kura Oncology, Inc. | 11 | Jan 27, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|